Niacin Extended Release Tablets — Class II drug recall D-396-2014
Terminated recall by Teva Pharmaceuticals USA, reported 2014-01-08, distributed nationwide. Failed Tablet/Capsule Specifications: There is a potential for broken tablets.
| Recall number | D-396-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Horsham, PA, United States |
| Recall initiated | 2013-11-26 |
| Classified | 2014-01-02 |
| Reported by FDA | 2014-01-08 |
| Terminated | 2014-08-27 |
| Distributed | Nationwide (US) |
| Quantity | 10,512 bottles |
| NDC | 00093-7392-98 |
| Lot numbers | 32900349B |
| Expiration dates | 2014-12 |
Product
Niacin Extended Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., Sellersville, PA, 18960, NDC 0093-7392-98
Reason for recall
Failed Tablet/Capsule Specifications: There is a potential for broken tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-396-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.